The TCR-based therapy market is projected to grow at an annualized rate of 51%, claims Roots Analysis
Given the recent approval of a TCR-based therapy, industry stakeholders have initiated several R&D efforts focused on evaluating the potential of such therapy candidates against various disease indications
